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The previous publications and the Letter of the New Zealand group have clearly shown that different fructosamine values can be obtained by using different calibrants in their assay. Adoption ofsecondary standards of any type does not alleviate the basic problem of calibration (12), because the fructosamine concentrations of these longer or shorter incubation times, and a longer wavelength, whereas a smaller sample volume and a shorter wavelength gave lower results. Thus, the fructosamine assay may be inexpensive, practicable, and easy to automate, but it is not robust.
in addition to the considerable analytical difficulties, none of which appear to be easy to resolve, there are also several problems in the clinical interpretation of results.
We have shown (1 ) that, for fructosamine, the ratio of intra-to interindividual variation is low, demonstrating that population-based reference values are of limited usefulness and may be misleading. Also, fructosamine concentrations in diabetics overlap considerably with those found in the healthy, rendering the test unsuitable for diagnosis or for use in screening programs.
Furthermore, fructosamine concentrations are dependent on the rate of protein turnover and are therefore influenced by thyrometabolic status (14). It may be that fructosamine depends on superoxide dismutase status (15). In addition, fructosainine concentrations increase with age (16), so that stratified reference values are required.
The major published rationale for the clinical use of fructosamine determinations is that fructosamine and hemoglobin A1,,concentrations are significantly correlated. The truly pertinent question to pose, therefore, is whether fructosamine assays should be adopted either in addition to or perhaps, in the current economic climate, as a replacement for hemoglobin A1,, assays. We believe, as do Sundkvist et al. (1 7 
Reappraisal of Carnitine Concentrations in Blood
To the Editor: Katrib et al.
(1) recently reported concentrations offree and acylated carnitine in whole blood, plasma, polymorphonuclear leukocytes (PMN), mononuclear cells (MNC), and erythrocytes. We isolated PMN from eight healthy adults according to the method of Metcoff (2) and determined concentrations of free carnitine (FC), shortchain acylcarnitmne (SCC), and longchain acylcarnitine (LCC) by applying the method of ROssle et al. (3), after disruption by thawing and freezing two times, followed by somcation. We also measured concentrations of the carnitine fractions in whole blood and in plasma, erythrocytes, and leukocytes (PMN and MNC) in four healthy adults, following the same isolation procedures as applied by Katrib et al.
(1), but using the above-described method of disruption. Our results are shown in the following tabulation.
Obviously, we observed considerably lower concentrations of total carnitine (TC) and its subfractions in leukocytes buffer.
Because Tris buffer may act as acetyl acceptor for carnitine acetyltransferase (6), presumably it could interfere with their assay. 
HrsT (HTLV-IIIILAV)
antibody positive (2, 3) . Wu et al. have made the point that the frequency ofordering f3-M is low. The question to be raised, therefore, is why this is so, despite its documented uses (4-6). Typically, the response we hear is that f3-M is not specific and that it may possibly be partially denatured in acid urine-correct, but in our opinion not a real reason for the limited use of /3-M assay. We say this because the specificity issue (e.g., the nature of the disease) is usually resolved by the time one would consider requesting a assay. It must be remembered that the true value of measuring /3-M is to assist in prognosis and followup.
Other 
MedIcine-LongItudInal Profiles of Secretion In Healthy Men
To the Editor:
The functional significance of the principal pineal hormone, melatonin, has yet to be established (1). Current thinking proposes a human neuroendocrine role, perhaps in some way similar to that documented in animals (2, 3), but no convincing endocrinology has been ascribed to date (1, 4) . Currently
